<DOC>
	<DOCNO>NCT01774903</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Transdermal Therapeutic System ( TTS ) -fentanyl patch ( transdermal patch contain drug put skin drug enter body skin ) severe ( serious , life threaten ) chronic ( last long time ) low back pain Thai participant .</brief_summary>
	<brief_title>An Efficacy Safety Study Transdermal Therapeutic System ( TTS ) -Fentanyl Severe Chronic Low Back Pain</brief_title>
	<detailed_description>This open label ( people know identity intervention ) , single arm , prospective ( study follow participant forward time ) study conduct assess efficacy safety TTS-fentanyl Thai participant chronic low back pain . All participant start treatment 12.5 microgram ( Âµg ) per hour patch . The patch replace every 3 day . On Day 3 , every 3 day thereafter , TTS-fentanyl dose increase consider base rescue medication consumption pain assessment . No increase TTS-fentanyl dose perform within 72-hour dose interval . The duration treatment 30 day . Primary efficacy assessment pain control rat participant . Assessment time point Day 0 ( baseline ) , Day 15 Day 30 ( trial end ) . At end study , global preference efficacy , side effect overall satisfaction also rat investigator participant . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Chronic low back pain moderate severe pain least 3 month Participants need treat strong opioid n't treat strong opioid past Participants still moderate severe pain ( Visual Analog Scale [ VAS ] &gt; = 4 ) , adequately control weak opioids tramadol codeine optimal dos ( least 120 milligram [ mg ] per day tramadol 200 mg per day codeine ) least 7 consecutive day Participants fail treatment operation lack efficacy current treatment Participant sign informed consent form Exclusion Criteria : Skin disease prevent use transdermal system could affect absorption fentanyl local tolerability History suspicion alcohol drug abuse within past 5 year History cardiac , nervous system respiratory disease investigator 's judgment preclude participation study potential respiratory depression Concomitant use Non Steroidal AntiInflammatory Drugs ( NSAIDs ) , Cyclooxygenase 2 ( COX2 ) , muscle relaxant , topical analgesic previous week ( unless stable drug dose least 1 month study entry ) Pregnancy breastfeed female ; female participant childbearing potential without adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Low Back Pain</keyword>
	<keyword>TTS-fentanyl</keyword>
	<keyword>Durogesic</keyword>
</DOC>